I. Sobhani et al., ANTIBIOTIC VERSUS MAINTENANCE THERAPY IN THE PREVENTION OF DUODENAL-ULCER RECURRENCE - RESULTS OF A MULTICENTRIC DOUBLE-BLIND RANDOMIZED TRIAL, Gastroenterologie clinique et biologique, 19(3), 1995, pp. 252-258
Objectives. - Reduction of gastric acid secretion by maintenance thera
py and eradication of Helicobacter pylori by antibiotic treatment have
been shown to reduce duodenal ulcer relapse. This study compared the
effect of two regimens, a 6-month maintenance on an H-2 receptor antag
onist versus a one-week antibiotic therapy, on the rate of duodenal ul
cer relapse in duodenal ulcer patients with gastric H. pylori infectio
n. Methods. - We conducted a 30-week, double-blind, double-dummy, mult
icentric clinical trial involving 119 patients (97 M, 22 F, mean age 3
9 +/- 14 years) randomly assigned to a daily dose of 40 mg famotidine
for 6 weeks supplemented with, during the first week, either antibioti
cs (500 mg amoxicillin q.i.d. and 500 mg tinidazole t.i.d. antibiotic
group) or their placebo (maintenance group). Healed patients after 6 w
eeks entered the 6-month maintenance phase: the maintenance group rece
ived 20 mg famotidine at bedtime and the antibiotic group, a placebo.
Endoscopy with antral biopsies was performed to allow a rapid urease t
est, culture and histological examination upon entry, after 6 weeks, 3
months, and 6 months and, whenever symptoms recurred H. pylori status
was regarded as positive if any one of these three rests was positive
, and negative if all tests were negative. Results. - The 2 treatment
groups were well balanced for all baseline characteristics. After 6 we
eks, H. pylori was eradicated in 25 (45 %) patients in the antibiotic
group, and in 1 (2 %) in the maintenance group (P < 0.01). In term of
intention-to-treat, there was no significant difference in the healing
rate after 6 weeks (93 and 83 % in the antibiotic and maintenance gro
ups, respectively; P = 0.15) or in the relapse rate after 6 months (13
and 28 % in the antibiotic and maintenance groups, respectively; P =
0.17 Log-rank test). However, the overall failure rate (absence of hea
ling, relapse) was lower (P = 0.04, Log-rank test) in the antibiotic g
roup in which all relapses but one were observed in H. pylori positive
patients. The rate of ulcer relapse (1/20) in patients of antibiotic
group who remained free of H. pylori during the study, was significant
ly (P < 0.01) lower compared with that of H. pylori positive patients
in the maintenance group (11/44). During the first 6-week period, more
side effects were observed in the antibiotic group than in the mainte
nance group (4 vs 1 patient, respectively). Conclusions. - Our results
indicate no significant difference between ulcer relapse rates after
6 months following a one-week antibiotic therapy or long-term maintena
nce therapy. Short-term antibiotic therapy should be considered as a v
aluable alternative to the long-term maintenance therapy.